APA (7th ed.) Citation

E, C., M, C., S, I., M, M., S, M., J, P., . . . F, M. (2015). Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction. Nanomedicine (London, England), 10(1), 9. https://doi.org/10.2217/nnm.13.208

Chicago Style (17th ed.) Citation

E, Cova, et al. "Antibody-engineered Nanoparticles Selectively Inhibit Mesenchymal Cells Isolated from Patients with Chronic Lung Allograft Dysfunction." Nanomedicine (London, England) 10, no. 1 (2015): 9. https://doi.org/10.2217/nnm.13.208.

MLA (9th ed.) Citation

E, Cova, et al. "Antibody-engineered Nanoparticles Selectively Inhibit Mesenchymal Cells Isolated from Patients with Chronic Lung Allograft Dysfunction." Nanomedicine (London, England), vol. 10, no. 1, 2015, p. 9, https://doi.org/10.2217/nnm.13.208.